These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
191 related items for PubMed ID: 7953192
1. Temperature-dependent alteration of 1,25-dihydroxy-vitamin D3 receptor macromolecules in MC3T3-E1 cells: affinity of hexafluoro analog of 1,25-dihydroxyvitamin D3, ST-630, for these forms. Tanaka M, Muramatsu M, Higuchi S, Otomo S. Res Commun Mol Pathol Pharmacol; 1994 Jul; 85(1):3-13. PubMed ID: 7953192 [Abstract] [Full Text] [Related]
2. Influence of 1,25-dihydroxyvitamin D3 on cultured osteogenic sarcoma cells: correlation with the 1,25-dihydroxyvitamin D3 receptor. Dokoh S, Donaldson CA, Haussler MR. Cancer Res; 1984 May; 44(5):2103-9. PubMed ID: 6324995 [Abstract] [Full Text] [Related]
3. Demonstration of 1 alpha,25-dihydroxyvitamin D3 receptor-like molecule in ST 13 and 3T3 L1 preadipocytes and its inhibitory effects on preadipocyte differentiation. Sato M, Hiragun A. J Cell Physiol; 1988 Jun; 135(3):545-50. PubMed ID: 2840436 [Abstract] [Full Text] [Related]
4. 1 alpha,25-Dihydroxyvitamin D3-binding macromolecules in human B lymphocytes: effects on immunoglobulin production. Provvedini DM, Tsoukas CD, Deftos LJ, Manolagas SC. J Immunol; 1986 Apr 15; 136(8):2734-40. PubMed ID: 3007606 [Abstract] [Full Text] [Related]
5. Differences in metabolism between 26,26,26,27,27,27-hexafluoro-1 alpha, 25-dihydroxyvitamin D3 and 1 alpha, 25-dihydroxyvitamin D3 in cultured neonatal mouse calvaria. Harada M, Miyahara T, Kajita-Kondo S, Kozakai A, Higuchi S, Otomo S, Kozuka H. Res Commun Mol Pathol Pharmacol; 1994 Nov 15; 86(2):183-93. PubMed ID: 7881867 [Abstract] [Full Text] [Related]
6. Hydrocortisone and deflazacort induce different effects on vitamin D receptor level increase produced by 1,25-dihydroxyvitamin D3 in rat osteoblast-like UMR-106 cells. Guerrero R, de la Piedra C, Teixeiro E, Bragado R, Traba ML. J Rheumatol; 2004 Jan 15; 31(1):167-72. PubMed ID: 14705237 [Abstract] [Full Text] [Related]
7. The human prostatic carcinoma cell line LNCaP expresses biologically active, specific receptors for 1 alpha,25-dihydroxyvitamin D3. Miller GJ, Stapleton GE, Ferrara JA, Lucia MS, Pfister S, Hedlund TE, Upadhya P. Cancer Res; 1992 Feb 01; 52(3):515-20. PubMed ID: 1370648 [Abstract] [Full Text] [Related]
8. A highly potent 26,27-Hexafluoro-1a,25-dihydroxyvitamin D3 on calcification in SV40-transformed human fetal osteoblastic cells. Miyahara T, Simoura T, Osahune N, Uchida Y, Sakuma T, Nemoto N, Kozakai A, Takamura T, Yamazaki R, Higuchi S, Chiba H, Iba K, Sawada N. Calcif Tissue Int; 2002 Jun 01; 70(6):488-95. PubMed ID: 12016462 [Abstract] [Full Text] [Related]
10. Identification of the subdomain in the nuclear receptor for the hormonal form of vitamin D3, 1 alpha,25-dihydroxyvitamin D3, vitamin D receptor, that is covalently modified by an affinity labeling reagent. Swamy N, Kounine M, Ray R. Arch Biochem Biophys; 1997 Dec 01; 348(1):91-5. PubMed ID: 9390178 [Abstract] [Full Text] [Related]
12. Murine osteoblast interleukin 4 receptor expression: upregulation by 1,25 dihydroxyvitamin D3. Lacey DL, Erdmann JM, Tan HL, Ohara J. J Cell Biochem; 1993 Oct 01; 53(2):122-34. PubMed ID: 8227185 [Abstract] [Full Text] [Related]
13. Specific uptake of 1,25-dihydroxycholecalciferol by human chronic myeloid leukemia cells. Freake HC, Iwasaki J, McCarthy DM. Cancer Res; 1984 Aug 01; 44(8):3627-31. PubMed ID: 6331655 [Abstract] [Full Text] [Related]
14. Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues. Norman AW, Sergeev IN, Bishop JE, Okamura WH. Cancer Res; 1993 Sep 01; 53(17):3935-42. PubMed ID: 8395333 [Abstract] [Full Text] [Related]
15. High performance liquid chromatography analysis of 1,25-dihydroxyvitamin D3 receptor in malignant cells. Correlation of effects on cell proliferation and receptor concentration. Thomas GA, Simpson RU. Cancer Biochem Biophys; 1986 Jul 01; 8(3):221-34. PubMed ID: 3017543 [Abstract] [Full Text] [Related]
16. Evidence for a 1 alpha,25-dihydroxyvitamin D3 receptor/binding protein in a membrane fraction isolated from a chick tibial fracture-healing callus. Kato A, Bishop JE, Norman AW. Biochem Biophys Res Commun; 1998 Mar 27; 244(3):724-7. PubMed ID: 9535732 [Abstract] [Full Text] [Related]
17. 1,25-Dihydroxyvitamin D3 [1,25-(OH)2D3] increases insulin-like growth factor I (IGF-I) receptors in clonal osteoblastic cells. Study on interaction of IGF-I and 1,25-(OH)2D3. Kurose H, Yamaoka K, Okada S, Nakajima S, Seino Y. Endocrinology; 1990 Apr 27; 126(4):2088-94. PubMed ID: 2156680 [Abstract] [Full Text] [Related]
18. Impaired stimulation of 25-hydroxyvitamin D-24-hydroxylase in fibroblasts from a patient with vitamin D-dependent rickets, type II. A form of receptor-positive resistance to 1,25-dihydroxyvitamin D3. Griffin JE, Zerwekh JE. J Clin Invest; 1983 Oct 27; 72(4):1190-9. PubMed ID: 6313754 [Abstract] [Full Text] [Related]
19. Effect of a highly potent fluoro analog of 1,25-dihydroxyvitamin D3 on human bone-derived cells. Kiriyama T, Okamoto S, Ejima E, Kurihara N, Hakeda Y, Ito N, Izumi M, Kumegawa M, Nagataki S. Endocrinology; 1991 Jan 27; 128(1):81-6. PubMed ID: 1846118 [Abstract] [Full Text] [Related]
20. Growth inhibitory effects on human colon adenocarcinoma-derived Caco-2 cells and calcemic potential of 1 alpha,25-dihydroxyvitamin D3 analogs: structure-function relationships. Bischof MG, Redlich K, Schiller C, Chirayath MV, Uskokovic M, Peterlik M, Cross HS. J Pharmacol Exp Ther; 1995 Dec 27; 275(3):1254-60. PubMed ID: 8531089 [Abstract] [Full Text] [Related] Page: [Next] [New Search]